Accel Brands (ACLP) 10-Q 20 May 15 2015 Q3 Quarterly report Financial data

Document_and_Entity_Informatio

Document and Entity Information	9 Months Ended
	Mar. 31, 2015	20-May-15
Document and Entity Information:
Entity Registrant Name	ACCEL BRANDS, INC.
Entity Trading Symbol	ACLP
Document Type	10-Q
Document Period End Date	31-Mar-15
Amendment Flag	FALSE
Entity Central Index Key	1077800
Current Fiscal Year End Date	-24
Entity Common Stock, Shares Outstanding		794,186,045
Entity Filer Category	Smaller Reporting Company
Entity Current Reporting Status	Yes
Entity Voluntary Filers	No
Entity Well-known Seasoned Issuer	No
Document Fiscal Year Focus	2015
Document Fiscal Period Focus	Q3

Consolidated_Balance_Sheets_Un

Consolidated Balance Sheets (Unaudited) (USD $)	Mar. 31, 2015	Jun. 30, 2014
Assets {1}
Cash and cash equivalents	$4,109	$26,640
Accounts Receivable	29,617	0
Inventory	190,325	0
Note Receivable	35,000	0
Deferred Financing costs	207	1,470
Other Current Assets	34,352	0
Total current assets	293,610	28,110
Property and equipment - net	45,258	59,598
Other Capitalized costs	49,130	0
Investment in Unconsolidated Subsidiary	0	1,039,074
Goodwill	4,279,861	0
Total non-current assets	4,384,429	1,098,672
Total assets	4,667,859	1,126,782
Current Liabilities
Accounts payable	1,261,579	1,261,579
Accrued expenses	1,635,491	406,593
Accrued compensation	351,555	371,555
Accrued Dividends	77,110	0
Liability for restricted common shares to be issued	55,000	0
Derivative Liability	901,387	66,962
Amounts due to Management of Consolidated Subsidiary	334,898	0
Current portion of notes payable- net of discounts of $ 178,460 and $126,722 at March 31 , 2015 and June 30, 2014 , respectively	868,831	647,448
Non-convertible debt- current	481,684	0
Total current liabilities	5,967,534	2,754,138
Long-term portion of non-convertible debt	0	0
Other Long Term Obligations	8,500	0
Total Non-current Liabilities	8,500	0
Total Liabilities	5,976,034	2,754,138
Stockholders' (Deficit)
Preferred stock- Series E 5% Convertible; stated value $1,000 per share; -0- issued and outstanding at March 31 2015 and June 30, 2014, respectively	0	0
Preferred stock- Series F Convertible; stated value $1,000 per share; 90 shares issued and outstanding at March 31, 2015 and June 30, 2014, Liquidation preference, $90,000	0	0
Preferred stock- Series G Convertible; stated value $1,000 per share; No shares issued and outstanding at March 31, 2015 and June 30, 2014	0	0
Preferred stock- Series H Convertible; stated value $1,000 per share; 51 shares issued and outstanding at March 31, 2015 and June 30, 2014	0	0
Preferred stock- Series I Convertible; stated value $1,000 per share; -0- and 3,500 shares issued and outstanding at March 31, 2015 and June 30, 2014, respectively. Par value $.001, 3,500 shares authorized	0	4
Preferred stock- Series J 10% Convertible; stated value $1,000 per share; 1,525 and -0- shares issued and outstanding at March 31, 2015 and June 30, 2014. Par value $.001, 3,500 shares authorized. Liquidation preference of $1,525,000 at March 31, 2015	2	0
Preferred stock- Series K 10% Convertible; stated value $1,000 per share; 750 and -0- issued and outstanding at March 31, 2015 and June 30, 2014, respectively. Par value $.001, 3,500 shares authorized. Liquidation preference of $750,000 at March 31, 2015	1	0
Common stock, $0.001 par value, 9,950,000,000 shares authorized; 685,019,378 and 16,485,064 issued and outstanding at March 31, 2015 and June 30, 2014, respectively	685,019	16,485
Additional paid-in capital	11,580,282	8,537,314
Accumulated Deficit	-13,270,130	-9,979,082
Total stockholders' (deficit) of AccelPath, Inc.	-1,004,826	-1,425,279
Non-Controlling interest	-303,348	-202,077
Total stockholders' (deficit)	-1,308,175	-1,627,356
Total liabilities and stockholders' (deficit)	$4,667,859	$1,126,782

BALANCE_SHEETS_PARENTHETICALS_

BALANCE SHEETS PARENTHETICALS (Unaudited) (USD $)	Mar. 31, 2015	Jun. 30, 2014
Parentheticals
Common Stock, par value	$0.00	$0.00
Common Stock, Shares Authorized	9,950,000,000	9,950,000,000
Common Stock, Shares Issued	685,019,378	16,485,064
Common Stock, Shares Outstanding	685,019,378	16,485,064
Preferred stock- Series E 5% Convertible stated value per share	$1,000	$1,000
Preferred stock- Series E 5% Convertible shares issued	0	0
Preferred stock- Series E 5% Convertible shares outstanding	0	0
Preferred stock- Series F Convertible; stated value per share	$1,000	$1,000
Preferred stock- Series F Convertible; shares issued	90	90
Preferred stock- Series F Convertible; shares outstanding	90	90
Preference - Series F in liquidation shares amounted	$90,000	$90,000
Preferred stock- Series G Convertible; stated value per share	$1,000	$1,000
Preferred stock- Series G Convertible; shares issued	0	0
Preferred stock- Series G Convertible; shares outstanding	0	0
Preferred stock- Series H Convertible; stated value per share	$1,000	$1,000
Preferred stock- Series H Convertible; shares issued	51	51
Preferred stock- Series H Convertible; shares outstanding	51	51
Preferred stock- Series I Convertible; stated value per share	1,000	1,000
Preferred stock- Series I Convertible; shares issued	0	3,500
Preferred stock- Series I Convertible; shares outstanding	0	3,500
Preferred stock- Series J 10 % Convertible; stated value per share	$1,000	$1,000
Preferred stock- Series J 10 % Convertible; shares issued	1,525	0
Preferred stock- Series J 10 % Convertible; shares outstanding	1,525	0
Preferred stock- Series J 10% Convertible; par value	$0.00	$0.00
Preferred stock- Series J 10% Convertible; Shares Authorized	3,500	3,500
Preference - series J 10% in liquidation shares amounted	1,525,000	0
Preferred stock- Series K 10 % Convertible; stated value per share	$1,000	$1,000
Preferred stock- Series K 10 % Convertible; shares issued	750	0
Preferred stock- Series K 10 % Convertible; shares outstanding	750	0
Preferred stock- Series K 10% Convertible; par value	$0.00	$0.00
Preferred stock- Series K 10% Convertible; Shares Authorized	3,500	3,500
Preference - series K 10% in liquidation shares amounted	750,000	0
Net discount of Current notes payable	$178,460	$126,722

Consolidated_Statements_of_Ope

Consolidated Statements of Operations (Unaudited) (USD $)	3 Months Ended		9 Months Ended
	Mar. 31, 2015	Mar. 31, 2014	Mar. 31, 2015	Mar. 31, 2014
REVENUE:
Revenues	$0	$54,000	$58,581	$162,000
Cost of Revenues	0	0	5,779	0
Gross Profits	0	54,000	52,802	162,000
Operating Expenses
Selling General and Administrative Expenses	267,254	-155,498	710,617	557,025
Total Operating Expenses	267,254	-155,498	710,617	557,025
Operating Income (Loss)	-267,254	209,498	-657,815	-395,025
Other Income (Expense)
Interest expense	-152,473	-137,181	-444,937	-305,113
Loss on Conversion of Debt	0	0	-367,575	-310,836
Derivative Liability Expense	-145,018	0	-369,539	0
Adjustment to Fair Value of Derivative Liability	-155,395	0	-21,123	0
Technology licensing Income	0	3,024	0	9,525
Total Other Income (Expense) - net	-452,885	-134,157	-1,203,174	-606,424
Net Income (Loss)	-720,140	75,341	-1,860,990	-1,001,449
Net income (Loss) attributable to non-controlling interest	101,271	0	101,271	0
Net Income (Loss) Accelpath, Inc.	-618,868	75,341	-1,759,718	-1,001,449
Deemed and cash dividends to Preferred Stockholders	-77,110	-1,139	-77,110	-1,139
Net loss applicable to Common shareholders	($695,978)	$74,202	($1,836,828)	($1,002,588)
Net loss per common share - basic and diluted	$0	$0.02	($0.01)	($0.37)
Weighted average number of common shares outstanding during the period/year - basic and diluted	685,019,378	3,970,198	330,095,798	2,694,285

Consolidated_Statements_of_Sto

Consolidated Statements of Stockholders Equity (Deficit) (Unaudited) (USD $)	Preferred stock Series E	Preferred stock Series F	Preferred stock Series G	Preferred stock Series H	Preferred stock Series I	Preferred stock Series J	Preferred stock Series K	Common Stock Shares	Common Stock Amount	Additional Paid-In Capital	Accumulated Deficit	Non-Controlling Interest in Subsidiary	Total Stockholders' Equity (Deficit)
	USD ($)		USD ($)	USD ($)	USD ($)	USD ($)		USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)
Balance at Jun. 30, 2014		0			4			16,485,064	16,485	8,537,314	-9,979,082	-202,077	-1,627,356
Shares issued for conversion of debt								608,833,551	608,834	-50,547			558,287
Shares issued for 3a10 program								$59,697,000	$59,697	($25,345)			$34,352
Fractional shares issued for reverse split								3,763	4				4
Write-down of Investment in Unconsolidated subsidiary					-4					-1,039,071			-1,039,074
Issuance of Series J Preferred Stock				0		2				2,145,488			2,145,489
Accumulated net loss in Village Tea upon acquisition			0								-608,837
Issuance of Series K Preferred Stock							1			2,089,551			2,089,552
Accumulated net loss in STI upon acquisition											-922,493		-922,493
Minority Gain (loss) in results of operations from consolidated subsidiaries	0											-101,271	-101,271
Dividends Accrued on Series J and Series K Preferred stock										-77,110			-77,110
Net loss											($1,759,718)		($1,759,718)
Balance at Mar. 31, 2015		0				2	1	685,019,378	685,019	11,580,282	-13,270,130	-303,348	-1,308,175

CONSOLIDATED_STATEMENTS_OF_CAS

CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) (USD $)	9 Months Ended
	Mar. 31, 2015	Mar. 31, 2014
CASH FLOWS FROM OPERATING ACTIVITIES:
Net Income (Loss) Accel Brands, Inc.	($1,759,718)	($1,001,449)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:
Loss from Conversion of debt	367,575	310,836
Stock based compensation	0	401,102
Depreciation and amortization of property and equipment	14,340	14,340
Amortization of Deferred Financing Costs	3,764	0
Amortization of note payable discount	393,262	259,343
Derivative Liability Expense	369,539	0
Adjustment to Fair Value of Derivative Liability	21,123	0
Amortization of Original Issue Discount	247	6,444
Accrued interest and legal fees issued for notes	18,587	3,426
Previously Accrued dividends converted to notes payable	0	13,143
Reduction in liabilities for issuance of common stock	0	12,091
Changes in operating assets and liabilities:
Decrease (increase) in accounts receivable	-29,617	0
Decrease (increase) in Inventory	-190,325	0
Decrease (increase) in Notes Receivable	-35,000	0
Increase (decrease) in Accrued Expenses and other liabilities	1,228,898	-387,692
Increase (decrease) in Accrued Compensation	-20,000	0
Cash expenditures for working capital items at consolidated subsidiaries	18,133	0
Net cash provided by (used in) operating activities	400,807	-368,416
CASH FLOWS FROM INVESTING ACTIVITIES:
Net working capital acquired in STI Signature Spirits Acquisition	-911,769	0
Net working capital acquired in Village tea Acquisition	45,931	0
Net cash used in investing activities	-865,838	0
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from issuance of notes payable, net of deferred financing costs	442,500	369,000
Net cash provided by financing activities	442,500	369,000
Net (Decrease) in Cash	-22,531	584
Cash - Beginning of Period/Year	26,640	1,201
Cash - End of Period/Year	4,109	1,785
SUPPLEMENTARY CASH FLOW INFORMATION:
Interest	0	0
Income Taxes	0	0
SUPPLEMENTARY DISCLOSURE OF NON-CASH INVESTING AND FINANCING ACTIVITIES:
Fair value of common stock warrants issued with convertible notes payable	0	0
Fair value of beneficial conversion feature on notes payable	0	369,000
Debt discount recorded on convertible debt accounted for as a derivative liability	445,000	0
Notes payable, accrued interest and other fees converted to common stock	221,786	0
Preferred Stock- Series E converted to Notes payable, including accrued dividends of $-0- and $14,282, respectively for September 30, 2014 and September 30, 2013	0	114,282
Cash dividend accrued on Preferred Stock-Series E	0	1,138
Change in Fair Value of Investment in Unconsolidated subsidiary	-1,039,074	0
Common stock issued for 3a10 program	34,352	0
Liquidation preference upon Issuance of Series J Convertible Preferred stock	1,525,000	0
Liquidation preference upon Issuance of Series K Convertible Preferred stock	750,000	0
Liability for restricted common shares to be issued	55,000	0
Accrued Dividends issued on Series J Preferred stock	66,014	0
Accrued Dividends issued on Series K Preferred stock	$11,096	$0

OVERVIEW_NATURE_OF_OPERATIONS_

OVERVIEW, NATURE OF OPERATIONS AND BASIS OF PRESENTATION	9 Months Ended
	Mar. 31, 2015
NATURE OF OPERATIONS AND BASIS OF PRESENTATION
NATURE OF OPERATIONS AND BASIS OF PRESENTATION
	1. OVERVIEW, CHANGE IN BUSINESS MODEL, NATURE OF OPERATIONS AND BASIS OF PRESENTATION
	Overview
	Accel Brands, Inc. (formerly - AccelPath, Inc.) (the “Company”) includes the following entities:
	Wholly-owned subsidiaries:
	Accelpath  LLC (“Accelpath”)
	Genex (See Item 5- Other Information for more detail)
	Majority Owned Subsidiaries:
	Village Tea Distributors Company, Inc. (“Village Tea”)  – 70% owned
	STI Signature Spirits Group, LLC (“STI”) . -52% owned
	Material Definitive Agreements
	Village Tea
	On October 16, 2014, Accel Brands entered into an Securities Purchase Agreement with the common stock and preferred stock shareholders (the “Sellers”) of Village Tea holding seventy percent (70%) of common stock and all the Series A Preferred Stock of Village Tea. Village Tea, is a provider of environmentally-friendly exotic teas sourced directly from growers throughout Asia and Africa. Combining exquisite taste with extraordinary health benefits, the Company plans to create a niche presence in the tea market and provide its products through leading health food retail chains, major retailers, specialty shops and its own outlets. Upon the closing of the transaction on October 24, 2014, Village Tea became a majority-owned subsidiary of Accel Brands. Accel Brands issued 1,525 shares of a newly designated series of convertible preferred stock to the Sellers, Series J. The Series J Preferred Stock has a stated value per share equal to $1,000, shall pay an annual dividend of 10% in cash or common stock, and shall be convertible at the holder’s option, subject to beneficial ownership limitations, into shares of the common stock of Accel Brands at a conversion price equal to eighty percent (80%) of the lowest closing bid price for the Common Stock during the thirty (30) trading days immediately preceding a Conversion Date. Accel Brands agreed to assume $538,500.00 worth of the debt obligations of Village Tea in connection with the Agreement.
	The foregoing information is a summary of the Agreement involved in the transaction described above, is not complete, and is qualified in its entirety by reference to the full text of the Agreement, which is attached an exhibit. Please see our Form 8-K filed October 16. 2014 and related exhibits incorporated by reference in this report for more detail.
	STI
	On February 5, 2015, The Company entered into a Securities Purchase Agreement (the “Agreement”) with STI, and the members of STI (collectively referred to as the Sellers).   Under the terms of the Agreement, the Sellers will sell 52.78 membership interests in STI, representing 52% of the outstanding membership units of STI (the “Majority Interest”), to the Company.  In exchange for the Majority Interest, the Company shall issue shares of a newly created Series K preferred stock (the “Preferred Stock”) with a stated value of $750,000 and $55,000 of restricted common stock of the Company and will assume $485,516.53 worth of STI’s debt.  Further, the Sellers shall be entitled to additional shares of Preferred Stock with a stated value of $2,250,000 pursuant to a three year earn out based on the number of units sold and booked by STI for each calendar year beginning the 2015.
	The foregoing information is a summary of the Agreement involved in the transaction described above, is not complete, and is qualified in its entirety by reference to the full text of the Agreement, which is attached an exhibit. Please see our Form 8-K filed February 10. 2015 and related exhibits incorporated by reference in this report for more detail.
	Change in Business Model and Nature of Operations
	Through the material definitive agreements cited above, the Company has changed its focus from a provider of pathological diagnostic services to a provider of high quality teas and spirits.  For segment reporting purposes, these are considered to be one segment, Beverages.  Our Beverage segment consists of Village Tea and STI.
	Village Tea, headquartered in National Harbor, MD is the owner of the Village Tea Company brand of premium loose leaf teas and tea accessories. We were incorporated in the State of Texas on January 11, 2011.
	Village Tea, sources high-quality, unique teas that are blended to create distinct flavor combinations which are packaged in a variety of creative and earth-friendly ways for wholesale and retail sales. The brand is currently available in several major retailers in North America including Vitamin Shoppe®, Whole Foods® Markets, Winners®, HomeSense® Akins/Chamberlin® Natural Foods Markets and many other independent specialty and grocery store retailers.  Village Tea products are also available through ecommerce retailers such as Amazon, the company's own website, www.villageteaco.com and others.
	STI headquartered in New York City is the owner of two brands of Tequila , Copa Imperial and Tiny’s Tequila. Both brands are very high quality and appeal to targeted niche segments. We are a State of New York limited liability company and began operations in January 2013.
	Copa Imperial
	Copa Imperial (“Copa”) is a premium tequila brand made in Mexico.  There are four products (the “Copa Tequilas”) : a) Tequila Blanco (“White Tequila”) , b) Tequila Reposado (“Tranquil Tequila), c) Tequila Anejo (“Old Tequila”) and d) Tequila Extra Anejo (“Very Old Tequila.”) Each product has its specific visual appearance, aromatic scent and taste that distinguishes itself from the others as well as competitive tequilas. The Copa Tequilas get their high quality through the use of 100% organic blue agave. In fact, the Copa Tequilas are the world’s first certified organic and kosher Tequila and get their distinctive taste through their mixture of ingredients and the aging process.
	The target market for the Copa Tequilas is professional men between 25 and 40 who drink occasionally but who enjoy a high quality experience when they drink.  They will be sold through high-end hotels and quality drinking establishments.
	Tiny’s Tequila
	Tiny’s Tequila is hosted by Grammy Award winning singer/songwriter Tameka “Tiny” Harris.  Tiny was looking to develop a line of premium infused sipping tequila that has great taste and minimal burn.  Currently, there are two products, Orange Blossom and Lime Light that are great tasting but also give a subtle finish.  All natural ingredients combined with a new age refinement give a wonderful taste.  This product line is geared mostly towards the young professional female. The Company provides the bottles for this work and receives a share of the proceeds when it is sold to the distributor.
	See our website at www.tinystequila.com for more information.
	Accelpath LLC, our pathology diagnostic service ceased to be active during the quarter ended December 31, 2014.
	Basis of Presentation
	The accompanying consolidated financial statements include the operations of the Company, its wholly-owned subsidiary Accelpath, LLC its 70% owned consolidated subsidiary, Village Tea and its 52% owned subsidiary, STI.
	The Company consolidates all entities in which the Company holds a “controlling financial interest.” For voting interest entities, the Company is considered to hold a controlling financial interest when the Company is able to exercise control over the investees’ operating and financial decisions. For variable interest entities (“VIEs”), the Company is considered to hold a controlling financial interest when it is determined to be the primary beneficiary. For VIEs, a primary beneficiary is a party that has both: (1) the power to direct the activities of a VIE that most significantly impact that entity's economic performance, and (2) the obligation to absorb losses, or the right to receive benefits, from the VIE that could potentially be significant to the VIE. The determination of whether an entity is a VIE is based on the amount and characteristics of the entity's equity.
	All significant inter-company balances and transactions have been eliminated in consolidation.
	The accompanying unaudited condensed consolidated financial statements of the Company have been prepared in accordance with accounting principles generally accepted in the United States of America for interim financial information, without being audited, pursuant to the rules and regulations of the Securities and Exchange Commission. Accordingly, they do not include all of the information and footnotes required by accounting principles generally accepted in the United States of America for complete financial statements. In the opinion of management, all adjustments considered necessary to make the financial statements not misleading have been included. Operating results for the three months ended March 31, 2015 are not necessarily indicative of the results that may be expected for the year ending June 30, 2015. The unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto included in the Company's Annual Report on Form 10-K for the year ended June 30, 2014 filed with the Securities and Exchange Commission.
	Recent Accounting Pronouncements
	There have been no recently issued accounting pronouncements that have had or are expected to have a material impact on the Company’s consolidated financial statements.

GOING_CONCERN_UNCERTAINTY_AND_

GOING CONCERN UNCERTAINTY AND MANAGEMENT'S PLAN	9 Months Ended
	Mar. 31, 2015
GOING CONCERN UNCERTAINTY AND MANAGEMENT'S PLAN:
GOING CONCERN UNCERTAINTY AND MANAGEMENT'S PLAN	2. GOING CONCERN UNCERTAINTY AND MANAGEMENT’S PLAN
	The accompanying financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America, which contemplate the continuation of the Company as a going concern. The Company had a net loss applicable to common shareholders of $1,836,828 for the nine months ended March 31, 2015 and a net loss applicable to common shareholders of $2,510,089 for the year ended June 30, 2014. Further, the Company had a working capital deficit of $5,673,925 and a stockholders’ deficit of $1,308,175 at March 31, 2015. These factors raise substantial doubt about the Company’s ability to continue as a going concern.
	Management is anticipating revenue growth through expansion of its customer base, and is also actively seeking financing through new and existing investors to fund operations. There is no assurance that the Company can reverse its net losses, or that the Company will be able to raise capital. These financial statements do not include any adjustments that might result from the outcome of this uncertainty.

OTHER_CURRENT_ASSETS_AND_ACCOU

OTHER CURRENT ASSETS AND ACCOUNTS PAYABLE.	9 Months Ended
	Mar. 31, 2015
OTHER CURRENT ASSETS AND ACCOUNTS PAYABLE
OTHER CURRENT ASSETS AND ACCOUNTS PAYABLE	3. OTHER CURRENT ASSETS AND ACCOUNTS PAYABLE
	On October 7, 2013, the Circuit Court in the Second Judicial District for Leon County, Florida entered an order approving the stipulation of the parties (the "Stipulation") in the matter of ASC Recap LLC ("ASC") v. Accel Brands, Inc. (the "Company"). Under the terms of the Stipulation, the Company agreed to issue to ASC, as settlement of certain liabilities owed by the Company in the aggregate amount of $1,537,455 (the "Claim Amount"), shares of common stock (the "Settlement Shares") as well as a promissory note in the principal amount of the $75,000.00 maturing six months from the date of issuance, as a fee to ASC ('Fee Note"). ASC had purchased the liabilities from the Company's creditors (both affiliated and non-affiliated) with a face amount of $1,537,455. The total amount of liabilities, as reported by the Company in this Form 10-Q for the quarter ended March 31, 2015, was $3,961,093, inclusive of the $1,612,455 representing the Claim Amount and the Fee Note.
	Pursuant to the Stipulation entered into by the parties, the Company agreed to issue to ASC, in one or more tranches as necessary, that number of shares of common stock sufficient to generate net proceeds (less a discount of twenty five percent (25%)) equal to the Claim Amount, as defined in the Stipulation. The parties reasonably estimated that, should the Company issue Settlement Shares sufficient to satisfy the entire Claim Amount, the fair market value of such Settlement Shares and all other amounts to be received by ASC would equal approximately $2,145,000. Notwithstanding anything to the contrary in the Stipulation, the number of shares beneficially owned by ASC shall not exceed 9.99% of the Company's outstanding common stock at any one time.
	In connection with the issuance of the Settlement Shares, the Company may rely on the exemption from registration provided by Section 3(a)(10) under the Securities Act. To date, the Company has issued 59,697,000 Settlement Shares to ASC. All of these shares were issued after the balance sheet date. As such, the full Claim Amount remains outstanding and payable to ASC at March 31, 2015. Based upon the reported closing trading price of the Company's common stock on May 19, 2015 of $.0001 per share, if all $2,145,000 worth of liabilities were satisfied pursuant to the Stipulation through the issuance of common stock, the Company would issue an aggregate of 2,145,000,000 shares, excluding the 59,697,000 shares already issued.
	As of the date of this filing, no proceeds from the sale of these shares have been used to repay creditors. At March 31, 2015, the value of the shares upon issuance is recorded as an Other Current Asset of $34,352.

CONVERTIBLE_NOTES_PAYABLE

CONVERTIBLE NOTES PAYABLE	9 Months Ended
	Mar. 31, 2015
CONVERTIBLE NOTES PAYABLE
CONVERTIBLE NOTES PAYABLE	4. CONVERTIBLE NOTES PAYABLE
	Notes payable – related parties and a third parties consist of the following:
		March 31,		June 30,
		2015		2014
	Note payable – former Managing Member	$	27,750	$	27,750
	Note payable – related corporation		4,300		4,300
	Notes payable – stockholders		13,000		13,000
	Convertible notes payable		977,241		729,120
	Total		1,022,291		774,170
	Convertible notes payable, discount		-178,460		-126,722
	Total, net of discount		868,831		647,448
	Less current portion		868,831		647,448
	Long-term debt	$	-	$	-
	All notes will mature prior to March 31, 2016
	During the current fiscal year, the Company has issued $270,000 of notes for consulting purposes and $172,500 in notes for cash.
	The consulting notes are comprised of nine $30,000 notes which mature between January 1, 2015 and January 1, 2016. They carry no interest and convert into common stock at a 50% discount to the low closing bid price over the prior thirty days
	The notes for cash are comprised of six notes which convert into common stock at anywhere between a 42% and 50% discount to the prevailing market price. All notes mature before December 31, 2015.
	Derivative Liability Feature on Notes Payable
	Prior to the fourth quarter of the prior fiscal year, for conventional convertible debt where the rate of conversion is based on a discount to the prevailing market value, the Company recorded a “beneficial conversion feature” (“BCF”) and related debt discount.
	The BCF was recorded as a debt discount against the face amount of the respective debt instrument. There would be an offsetting increase to Additional paid in capital as the BCF is deemed to be an increase to equity. The discount would be amortized to interest expense over the life of the debt.
	Commencing with the fourth quarter of the prior fiscal year, the Company reconsidered the requirements of the Financial Accounting Standards Board Accounting Standards Classification 820 (‘FASB ASC 820” or “ASC 820”) and determined that newly issued debt were derivative financial instruments. As such, a derivative expense was recorded on the issuance of the debt as well as a quarterly mark to market
	Interest Expense
	Interest expense on notes payable, including amortization of the discount on the convertible notes and the accrual of the Original Issue Discount, was $444,937 and $305,113 for the nine months ended March 31, 2015 and 2014, respectively.
	Interest expense on notes payable, including amortization of the discount on the convertible notes and the accrual of the Original Issue Discount, was $152,473 and $137,181 for the three months ended March 31, 2015 and 2014, respectively.

NONCONVERTIBLE_DEBT

NON-CONVERTIBLE DEBT	9 Months Ended
	Mar. 31, 2015
NON-CONVERTIBLE DEBT:
NON-CONVERTIBLE DEBT	5. NON-CONVERTIBLE DEBT
	The Company issued the following Note Payables.  All Notes of these Notes were issued at their majority-owned and consolidated Village Tea and STI subsidiaries
	2013
	Ten separate notes form an investor were received in 2013 as follows:
	Date Issued	Maturity Date		Interest rate	Amount
	23-Feb-13	30-Jun-14		10%	$	100,000
	February 27,2013	30-Jun-14		8%	$	1,500
	14-Mar-13	30-Jun-14		8%	$	6,500
	April 23,2013	30-Jun-14		8%	$	5,000
	9-May-13	30-Jun-14		8%	$	10,000
	30-Jun-13	30-Jun-14		8%	$	7,500
	11-Jul-13	30-Jun-14		8%	$	10,000
	29-Jul-13	30-Jun-14		8%	$	10,000
	23-Aug-13	June 30,2014		8%	$	13,000
	29-Aug-13	30-Jun-14		10%	$	9,000
	Various*	On demand		-0-%		12,184
	Total for 2013				$	184,684
	*- These notes are from employees and are non- interest bearing and unsecured.
	2012
	An investor lent the Company $80,000 for operating expenses throughout the year. These expenses were put forth in a note that matures on January 1, 2015 and carries no interest.
	2011
	Beverley Reif lent the Company $100,000 on March 15, 2011. The note bore an interest rate of 5% and matured on September 15, 2011. If the note were not paid by maturity, the interest rate would increase to 18%.
	Dana Pope lent the Company $57,000 on March 15, 2011. The note bore an interest rate of 5% and matured on September 15, 2011. If the note were not paid by maturity, the interest rate would increase to 18%.
	Both of these notes are currently subject to a litigation. See footnote 9 below.
	An investor lent the Company $60,000 for operating expenses throughout the year. These expenses were put forth in a note that matures on January 1, 2015 and carries no interest.
	Non-Convertible Debt Summary
	2011 notes	$	217,000
	2012 notes		80,000
	2013 notes		184,684
	Total Non-Convertible Debt	$	481,684

PREFERRED_STOCK

PREFERRED STOCK	9 Months Ended
	Mar. 31, 2015
PREFERRED STOCK
PREFERRED STOCK	6. PREFERRED STOCK
	Series E
	As of March 31, 2015, the Company has -0- outstanding shares of its Series E 5% Convertible Preferred Stock outstanding. During the quarter ended March 31, 2014, the Company exchanged its remaining 100 shares of Series E Preferred Stock plus $14,282 of accrued dividends into a new Secured Note of $114,282 (See Footnote Three above) The Company accrued cash dividends payable of $-0- and $1,139 for the three months ended March 31, 2015 and 2013, respectively. At March 31, 2015, there are no accrued dividends payable included in accrued expenses and other current liabilities.
	Series F
	On September 7, 2012, the Company authorized 100 shares of Series F Convertible Preferred Stock, with a stated value of $1,000. The Series F Preferred is convertible into common stock at any time at the option of the holder. The number of shares of common stock into which one share of Series F Preferred is convertible is determined by (i) dividing $1,000 (the stated value) outstanding by the closing bid price on the trading day immediately prior to the date of the conversion notice (the “Conversion Price”), and (ii) multiplying by ten; provided that if the closing bid price on such trading day is less than $0.02 per share ($5.00 post-split), then the Conversion Price shall be $0.02 ($5.00 post-split). Accordingly, the authorized 100 shares of Series F Preferred are currently convertible into 180,000 shares of common stock using a Conversion Price of $5.00.
	On September 10, 2012, the Company issued 90 shares of its Series F Preferred Stock for the purchase price of $90,000 to certain existing investors of the Company. The 90 shares of Series F Preferred are currently convertible into 180,000 shares of common stock. The Company determined that there was a beneficial conversion feature of $360,000 for the issuance of the 90 shares of Series F Preferred Stock. The beneficial conversion feature was calculated based on the effective conversion price per share compared to the fair value per share of common stock on the commitment date.
	Series G
	On September 18, 2012, the Company authorized 1,250 shares of Series G Convertible Preferred Stock, with a stated value of $1,000. The Series G Preferred is convertible into common stock at any time at the option of the holder three months after the date of issuance. After five years from the date of issuance or upon a change of control, the Series G Preferred is automatically converted into shares of common stock. The number of shares of common stock into which one share of Series G Preferred is convertible is determined by dividing $1,000 (the stated value) outstanding by the closing bid price on the trading day immediately prior to the date of the conversion notice (the “Conversion Price”); provided that if the closing bid price on such trading day is less than $0.02 per share, then the Conversion Price shall be $0.02. Accordingly, the authorized 1,250 shares of Series G Preferred are convertible into 62,500,000 shares of common stock at an assumed Conversion Price of $0.02. As of March 31, 2015 and 2013, there was no Series G Convertible Preferred Stock issued and outstanding.
	Series H
	The number, designation, rights, preferences and privileges of the Series H Preferred were established by the Board at a meeting on April 2, 2013. The designation, rights, preferences and privileges that the Board established for the Series H Preferred is set forth in a Certificate of Designation that was filed with the Secretary of State of the State of Delaware on April 3, 2013. Among other things, the Certificate of Designation provides that each one share of Series H Preferred has voting rights equal to (x) 0.019607  multiplied by  the total issued and outstanding Common Stock eligible to vote at the time of the respective vote (the "Numerator"),  divided by  (y) 0.49,  minus  (z) the Numerator.
	At a meeting of the Board, the Board issued an aggregate of fifty one (51) shares of Series H Preferred to one individual, Shekhar Wadekar, Chief Executive Officer of the Company. As a result of the voting rights granted to the Series H Preferred, the Series H Stockholder holds in the aggregate approximately 50.9989% of the total voting power of all issued and outstanding voting capital of the Company
	On March 21, 2014, ownership of the Series H Preferred was transferred to Mr. Steedley, our Chief Executive Officer.
	Series I
	As previously disclosed, on October 24, 2013, The Company and EIP entered into an Agreement and Plan of Reorganization in which EIP was to become a wholly-owned subsidiary of The Company. On October 9, 2014 EIP gave notice to Accel Brands of its intention to terminate the Agreement. As a result, the parties shall take all action required to unwind the transaction, including the return and surrender by The Company of the common stock its holds in EIP, and the return and surrender by EIP of its 3,500 shares of Series I Preferred Stock of The Company. The Company retired all shares of Series I Preferred Stock to treasury. As of the filing date of this report, there are -0- shares issued and outstanding of the Series I Preferred.
	See our 8-K filing of October 16, 2014 for more detail
	Series J
	On October 16, 2014, Accel Brands entered into a Securities Purchase Agreement with the common stock and preferred stock shareholders (the “Sellers”) of Village Tea Distributors, Inc. (“Village Tea”) holding seventy percent (70%) of common stock and all the Series A Preferred Stock of Village Tea. Upon the closing of the transaction on October 24, 2014, Village Tea became a majority-owned subsidiary of Accel Brands. Accel Brands issued 1,525 shares of a newly designated series of convertible preferred stock to the Sellers, which is designated as Series J Preferred Stock. The Series J Preferred Stock has a stated value per share equal to $1,000, shall pay an annual dividend of 10% in cash or common stock, and shall be convertible at the holder’s option, subject to beneficial ownership limitations, into shares of the common stock of Accel Brands at a conversion price equal to eighty percent (80%) of the lowest closing bid price for the Common Stock during the thirty (30) trading days immediately preceding a Conversion Date. Accel Brands agrees to assume the debt obligations of Village Tea in connection with the Agreement.
	The dividend has been fully accrued since issuance.
	Series K
	On February 5, 2015, The Company entered into a Securities Purchase Agreement (the “Agreement”) with STI Signature Spirits Group, LLC, a New York limited liability company (“STI”), and the members of STI (collectively referred to as the Sellers).   Under the terms of the Agreement, the Sellers will sell 52.78 membership interests in STI, representing 52% of the outstanding membership units of STI (the “Majority Interest”), to the Company.  In exchange for the Majority Interest, the Company shall issue shares of a newly created Series K preferred stock (the “Preferred Stock”) with a stated value of $750,000 and $55,000 of restricted common stock of the Company and will assume $485,516.53 worth of STI’s debt.  Further, the Sellers shall be entitled to additional shares of Preferred Stock with a stated value of $2,250,000 pursuant to a three year earn out based on the number of units sold and booked by STI for each calendar year beginning the 2015.
	The foregoing information is a summary of the Agreement involved in the transaction described above, is not complete, and is qualified in its entirety by reference to the full text of the Agreement, which is attached an exhibit. Please see our Form 8-K filed February 10. 2015 and related exhibits incorporated by reference in this report for more detail.
	The dividend has been fully accrued since issuance.

COMMON_STOCK

COMMON STOCK	9 Months Ended
	Mar. 31, 2015
COMMON STOCK:
COMMON STOCK	7. COMMON STOCK
	Our common stock is listed on the OTCBB and trades under the symbol ACLP. On September 4, 2014, there was a 1:250 reverse split.
	During the nine months ended March 31, 2015, the Company issued the following shares:
	608,833,551 shares pursuant to the conversion of debt, accrued interest and related expenses;
	59,697,000 shares pursuant to the 3a10 program;
	3,763 fractional shares associated with the reverse split of September 4, 2014.
	On March 7, 2011, the Company entered into an Equity Purchase Agreement. Pursuant to the Equity Purchase Agreement, a third party committed to purchase up to $5,000,000 of common stock over the course of 24 months commencing on the effective date of the registration statement pursuant to the registration rights agreement. The registration statement was declared effective on February 9, 2012. The purchase price of the common stock to be sold pursuant to the Equity Purchase Agreement will be 95% of the average of the lowest three closing bid prices, consecutive or inconsecutive, during the five trading day period commencing on the date a put notice requesting that a third party purchase. On July 19, 2012, the Company received proceeds of $6,000 for the sale of 2,807 (701,754 pre-split) shares of common stock pursuant to the Equity Purchase Agreement with a third party. The registration statement is no longer effective.

OPTIONS_WARRANTS_AND_STOCKBASE

OPTIONS, WARRANTS AND STOCK-BASED COMPENSATION	9 Months Ended
	Mar. 31, 2015
OPTIONS, WARRANTS AND STOCK-BASED COMPENSATION:
OPTIONS, WARRANTS AND STOCK-BASED COMPENSATION	8. OPTIONS, WARRANTS AND STOCK-BASED COMPENSATION
	2011 Equity Incentive Plan
	On March 4, 2011, the Board of Directors adopted the 2011 Equity Incentive Plan and reserved up to 50,000,000 shares of common stock for issuance to employees, directors and consultants, subject to stockholder approval. On February 17, 2012, the stockholders approved the plan. The plan also provides for automatic annual increases on January 1st of each year (commencing on January 1, 2012 and ending on January 1, 2021), in the aggregate number of shares reserved equal to the lesser of (a) five percent of the total number of shares outstanding on December 31st of the preceding year or (b) 3,000,000 shares. As of January 1, 2013, the number of shares reserved under the plan automatically increased to 56,000,000. Under the plan, the Board may grant stock options, stock appreciation rights, restricted stock awards, restricted stock unit awards, performance stock awards, performance cash awards and other stock awards.
	Valuation and amortization method. The fair value of each stock award is estimated on the grant date using the Black-Scholes option-pricing model. The estimated fair value of employee stock options is amortized to expense using the straight-line method over the vesting period.
	Volatility. The Company estimates volatility based on the Company’s historical volatility.
	Risk-free interest rate. The risk-free interest rate is based on the U.S. Treasury yield curve in effect at the time of grant commensurate with the expected term assumption.
	Expected term. The expected term of stock options granted is based on an estimate of when options will be exercised in the future. The Company applied the simplified method of estimating the expected term of the options, as described in the SEC’s Staff Accounting Bulletins 107 and 110, as the Company has had a significant change in its business operations and the historical experience is not indicative of the expected behavior in the future. The expected term, calculated under the simplified method, is applied to groups of stock options that have similar contractual terms. Using this method, the expected term is determined using the average of the vesting period and the contractual life of the stock options granted.
	Forfeitures. Stock-based compensation expense is recorded only for those awards that are expected to vest. FASB ASC Topic 718 requires forfeitures to be estimated at the time of grant and revised, if necessary, in subsequent periods if actual forfeitures differ from those estimates. The term “forfeitures” is distinct from “cancellations” or “expirations” and represents only the unvested portion of the surrendered option. An annual forfeiture rate of 0% was applied to all unvested options as of March 31, 2015 which was management’s best estimate. This analysis will be re-evaluated semi-annually and the forfeiture rate will be adjusted as necessary. Ultimately, the actual expense recognized over the vesting period will be for only those shares that vest.
	The following weighted average assumptions were used to estimate the fair value of stock options using the Black-Scholes option pricing model:
			Three Months Ended		Three Months Ended
			31-Mar-15		31-Mar-14
	Risk-free interest rate		0.62% - 0.72%		0.90% - 0.96%
	Expected dividend yield		-		-
	Expected term		3.25 - 5.5 years		5.5 years
	Forfeiture rate		0%		0%
	Expected volatility		244.90% - 262.52%		122.33% - 124.91%
	A summary of option activity as of March 31, 2015 and for the three months then ended is presented below. All information is presented pre-split:
	Options		Shares		Weighted Average Exercise Price		Weighted Average Remaining Contractual Term	Aggregate Intrinsic Value
	Outstanding at June 30, 2012		186,760		$	15	8.84 years	$	-
	Granted		-			-	-		-
	Exercised		-			-	-		-
	Forfeited or expired		-			-	-		-
	Outstanding at June 30, 2013		186,760		$	15	7.84 years	$	-
	Granted		-			-	-		-
	Exercised		-			-	-		-
	Forfeited		-			-	-		-
	Exercisable at June 30, 2014 and March 31, 2015		186,760		$	15	6.84 years	$	-
	On April 6, 2011, the Board of Directors granted stock options to purchase 169,450 shares of common stock at an exercise price of $16.25 per share. On May 13, 2011, the Board of Directors granted stock options to purchase 3,000 shares of common stock at an exercise price of $15.00 per share. The weighted average fair value of the options granted was estimated at $14.60 per share. These options vest over three years and have a term of 10 years.
	On August 12, 2011, the Board of Directors granted stock options to purchase 480 shares of common stock at an exercise price of $12.50 per share. The weighted average fair value of the options on the date of the grant was estimated at $10.75 per share. These options vest over one year and have a term of 10 years.
	On December 14, 2011, the Board of Directors granted stock options to purchase 10,000 shares of common stock at an exercise price of $3.75 per share. The weighted average fair value of the options on the date of the grant was estimated at $2.00 per share. These options vest monthly over 10 months and have a term of 10 years.
	On January 12, 2012, the Board of Directors granted stock options to purchase 480 shares of common stock at an exercise price of $1.25 per share. The weighted average fair value of the options on the date of the grant was estimated at $1.00 per share. These options vest over one year and have a term of 10 years.
	On June 3, 2012, the Board of Directors granted stock options to purchase 3,400 shares of common stock at an exercise price of $13.60 per share. The weighted average fair value of the options on the date of the grant was estimated at $3.88 per share. These options vest over three year and have a term of 10 years.
	On March 15, 2012, the Company agreed to issue a restricted stock award of 10,000 shares of common stock to a consultant for services to be rendered with 5,000 shares vesting on June 15, 2012 and 5,000 shares vesting on September 15, 2012. As of March 31, 2015, the shares had not been issued. Consulting expense recorded for the restricted stock award was $29,167 for the year ended June 30, 2012.
	Warrants
	The Company’s outstanding warrants remained in place subsequent to the reverse acquisition. No warrants were exercised during the year ended June 30, 2014 or the quarter ended March 31, 2015. On July 17, 2011, warrants to purchase 200,000 shares at $1.89 per share expired. During the year ended June 30, 2012, the Company issued 2,000,000 warrants in connection with convertible notes payable (see Note 8). The warrants have an exercise price of $2.50 per share, are immediately exercisable and expire in five years from issuance. No warrants were issued, exercised or expired in the year ended June 30, 2014. The Company has reserved 2,075,000 shares of common stock for the exercise of outstanding warrants. The following table summarizes the warrants outstanding at June 30, 2014 adjusted for the 1:250 stock split which took effect on September 4, 2014:
	Exercise price			Number		Expiration Date
	$	2.5		2,000		2/10/17
	$	2.5		4,000		2/17/17
	$	2.5		1,250		4/18/17
	$	2.5		800		8/15/17
	$	2.5		200		8/20/17
	$	2.5		1,000		9/14/17
	$	2.5		1,000		10/2/17
				10,250
	The weighted average grant date fair value of the warrants granted during the three months ended March 31, 2014 was $0.0095 per share. The warrants were valued using the Black-Scholes option pricing model. The following assumptions were used for warrants issued during the three months ended March 31, 2014; risk free interest rates of 0.60% - 0.72%; expected dividend yield of 0%; expected term of 5 years and expected volatility of 244.07% - 248.52%. The weighted average remaining life of the warrants at March 31, 2015 was 3.86 years. At March 31, 2015, all warrants are exercisable and there is no aggregate intrinsic value for the warrants outstanding.
	Stock Award Plan
	Under the 2006 Stock Award Plan the Company may award shares of common stock to employees, officers, directors, consultants and advisors and may make grants subject to such terms and conditions as determined by the Board of Directors. As of March 31, 2014, the Company has 111,845 shares available for future grant under the Plan.

NET_LOSS_PER_SHARE

NET LOSS PER SHARE	9 Months Ended
	Mar. 31, 2015
NET LOSS PER SHARE.
NET LOSS PER SHARE	9. NET LOSS PER SHARE
	Securities that could potentially dilute basic earnings (loss) per share ("EPS") as of March 31, 2015 and 2014, and that were not included in the computation of diluted EPS because to do so would have been anti-dilutive consist of the following:
		Potentially Outstanding
		Dilutive Common Shares
		For the Interim Period	For the Interim Period
		Ended	Ended
		March 31, 2015	March 31, 2014
	Preferred stock- Series E 5% Convertible; stated value $1,000 per share; -0-  issued and outstanding at March 31 2015 and June 30, 2014, respectively	-	-
		180,000	180,000
	Preferred stock- Series F Convertible; stated value $1,000 per share; 90 shares issued and outstanding at March  31, 2015 and June 30, 2014
		-	-
	Preferred stock- Series G Convertible; stated value $1,000 per share; No shares issued and outstanding at March 31, 2015 and June 30, 2014
		1	1
	Preferred stock- Series H Convertible; stated value $1,000 per share; 51 shares issued and outstanding at March 31, 2015 and June 30, 2014
		-	1,194,412
	Preferred stock- Series I Convertible; stated value $1,000 per share; -0- and 3,500 shares issued and outstanding at March 31, 2015 and June 30, 2014, respectively. Par value $.001, 3,500 shares authorized
		68,501,938	-
	Preferred stock- Series J 10% Convertible; stated value $1,000 per share; 1,525 and -0- shares issued and outstanding at March 31, 2015 and June 30, 2014, respectively. Par value $.001, 3,500 shares authorized. Liquidation preference of $1,525,000 at March 31, 2015
		68,501,938	-
	Preferred stock- Series K 10% Convertible; stated value $1,000 per share; 750 and -0- issued and outstanding at March 31, 2015 and June 30, 2014, respectively. Par value $.001, 3,500 shares authorized. Liquidation preference of $750,000 at March 31, 2015
		342,646,780	1,985,099
	Convertible Notes Payable*
	Stock options	186,760	186,760
	Restricted stock award	10,000	10,000
	Warrants	10,250	10,250
		480,037,667	3,566,522
	*- Maximum ownership is predicated upon 9.99% of outstanding shares at March 31, 2015 per contractual limitation of five holders. and March 31, 2014. There were five such holders at each balance sheet date.

COMMITMENTS_AND_CONTINGENCIES

COMMITMENTS AND CONTINGENCIES	9 Months Ended
	Mar. 31, 2015
COMMITMENTS AND CONTINGENCIES
COMMITMENTS AND CONTINGENCIES	10. COMMITMENTS AND CONTINGENCIES
	Operating Lease
	Currently, the Company rents space at 137 National Plaza, Suite 300, National Harbor, MD 20745on a month-to-month basis. Monthly rent approximates $275. There are no future minimum lease rental payments.
	Consulting Agreements
	The Company signed a consulting agreement which calls for a $30,000 monthly payment in the form of a convertible promissory note. For the three months and nine months ended March 31, 2015, the Company has incurred $90,000 and $270,000 respectively in such notes. See Note 4 for details on the Notes issued for these services.

EMPLOYEE_BENEFIT_PLAN

EMPLOYEE BENEFIT PLAN	9 Months Ended
	Mar. 31, 2015
EMPLOYEE BENEFIT PLAN:
EMPLOYEE BENEFIT PLAN
	11. EMPLOYEE BENEFIT PLAN
	The Company has a 401(k) plan for the benefit of certain employees. The Company had contributed to the plan under a safe harbor plan requiring a 3% contribution for all eligible participants. In addition, the Company may contribute a 3% elective match. Effective January 1, 2013, the Company amended the plan to remove the 3% safe harbor contribution. No contributions have been made in the current fiscal year. Contributions and other costs of the plan for the nine months ended March 31, 2015 were $-0-. Contributions and other costs of the plan for the nine months ended March 31, 2014 were $-0-.

OPERATING_SEGMENTS

OPERATING SEGMENTS	9 Months Ended
	Mar. 31, 2015
OPERATING SEGMENTS
OPERATING SEGMENTS	12. OPERATING SEGMENTS
	The Company had operated in three segments which are consistent with its internal organization. The major segments were Medical Diagnostic Services, Government Contracting and Beverages.  Government contracting has been inactive since 2012 and is now excluded as a segment.
	Revenues, expenses and assets not explicitly attributed to a segment are deemed to be unallocated.
	Data for the three and nine months ended March 31, 2015 and March 31, 2014 follow below:
			Three Months Ended March 31, 2015
			Medical Diagnostics		Beverages		Unallocated		Total
	Revenues	$	-	$	-	$	-	$	-
	Cost of Goods Sold		-		-		-		-
	Total Operating Expenses		4,780		150,271		112,203		267,254
	Operating Income (Loss)		-4,780		-150,271		-112,203		-155,052
	Other Income (Expense)		-		-10,853		-442,032		-452,885
	Net Income		-4,780		-161,125		-554,235		-607,937
	Total Assets	$	45,258	$	290,001	$	4,332,600	$	4,667,859
			Three Months Ended March 31, 2014
			Medical Diagnostics		Beverages		Unallocated		Total
	Revenues	$	54,000	$	-	$	-	$	54,000
	Cost of Goods Sold		-		-		-		-
	Total Operating Expenses		66,360		-		-221,858		-155,498
	Operating Income (Loss)		-12,360		-		221,858		209,498
	Other Income (Expense)		-3,024		-		-131,133		-134,157
	Net Income		-15,384		-		90,726		75,341
	Total Assets	$	64,378	$	-	$	1,039,074	$	1,103,452
			Nine Months Ended March 31, 2015
			Medical Diagnostics		Beverages		Unallocated		Total
	Revenues	$	54,000	$	4,581	$	-	$	58,581
	Cost of Goods Sold		-		5,779		-		5,779
	Total Operating Expenses		68,633		252,379		389,604		710,617
	Operating Income (Loss)		-14,633		-253,578		-389,604		-657,815
	Other Income (Expense)		-		-10,853		-1,192,321		-1,203,174
	Net Income		-14,633		-264,431		-1,581,926		-1,860,990
	Total Assets	$	45,258	$	290,001	$	4,332,600	$	4,667,859
			Nine Months Ended March 31, 2014
			Medical Diagnostics		Beverages		Unallocated		Total
	Revenues	$	162,000	$	-	$	-	$	162,000
	Cost of Goods Sold		-		-		-		-
	Total Operating Expenses		150,277		-		406,748		557,025
	Operating Income (Loss)		11,723		-		-406,748		-395,025
	Other Income (Expense)		3,024		-		-609,448		-606,424
	Net Income		14,747		-		-1,016,196		-1,001,449
	Total Assets	$	64,378	$	-	$	1,039,074	$	1,103,452

SUBSEQUENT_EVENTS

SUBSEQUENT EVENTS	9 Months Ended
	Mar. 31, 2015
SUBSEQUENT EVENTS
SUBSEQUENT EVENTS	13. SUBSEQUENT EVENTS
	The Company has evaluated all events that occurred after the balance sheet date through the date when the consolidated financial statements were issued to determine if they must be reported.  The Management of the Company determined that the following was a significant event.
	Issuance of Debt
	On April 1, 2015, the Company issued a note for $30,000 for consulting services. The convertible promissory note bears no interest and matures on October 31, 2015. The third party has the option to convert all or a portion of the note plus accrued interest into common stock at a conversion price equal to 50% of the lowest closing bid price for the twenty days prior to the conversion. As of the date of this filing, there have been no conversions of this Note and the entire amount is outstanding.
	On May 1, 2015, the Company issued a note for $30,000 for consulting services. The convertible promissory note bears no interest and matures on November 30, 2015. The third party has the option to convert all or a portion of the note plus accrued interest into common stock at a conversion price equal to 50% of the lowest closing bid price for the twenty days prior to the conversion. As of the date of this filing, there have been no conversions of this Note and the entire amount is outstanding.
	Issuance of Common stock
	Subsequent to the Balance Sheet date, the Company has issued 109,166,667 shares of common stock for the retirement of $5,500 of convertible debt and $300 of associated expenses.

SIGNIFICANT_ACCOUNTING_POLICIE

SIGNIFICANT ACCOUNTING POLICIES (POLICIES)	9 Months Ended
	Mar. 31, 2015
SIGNIFICANT ACCOUNTING POLICIES:
Basis of Presentation, Policy	Basis of Presentation
	The accompanying consolidated financial statements include the operations of the Company, its wholly-owned subsidiary Accelpath, LLC its 70% owned consolidated subsidiary, Village Tea and its 52% owned subsidiary, STI.
	The Company consolidates all entities in which the Company holds a “controlling financial interest.” For voting interest entities, the Company is considered to hold a controlling financial interest when the Company is able to exercise control over the investees’ operating and financial decisions. For variable interest entities (“VIEs”), the Company is considered to hold a controlling financial interest when it is determined to be the primary beneficiary. For VIEs, a primary beneficiary is a party that has both: (1) the power to direct the activities of a VIE that most significantly impact that entity's economic performance, and (2) the obligation to absorb losses, or the right to receive benefits, from the VIE that could potentially be significant to the VIE. The determination of whether an entity is a VIE is based on the amount and characteristics of the entity's equity.
	All significant inter-company balances and transactions have been eliminated in consolidation.
	The accompanying unaudited condensed consolidated financial statements of the Company have been prepared in accordance with accounting principles generally accepted in the United States of America for interim financial information, without being audited, pursuant to the rules and regulations of the Securities and Exchange Commission. Accordingly, they do not include all of the information and footnotes required by accounting principles generally accepted in the United States of America for complete financial statements. In the opinion of management, all adjustments considered necessary to make the financial statements not misleading have been included. Operating results for the three months ended March 31, 2015 are not necessarily indicative of the results that may be expected for the year ending June 30, 2015. The unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto included in the Company's Annual Report on Form 10-K for the year ended June 30, 2014 filed with the Securities and Exchange Commission.
Recent Accounting Pronouncements, Policy	Recent Accounting Pronouncements
	There have been no recently issued accounting pronouncements that have had or are expected to have a material impact on the Company’s consolidated financial statements.

Notes_PayableNotes_payable_rel

Notes PayableNotes payable - related parties and a third parties (TABLE)	9 Months Ended
	Mar. 31, 2015
Notes payable Related parties and a Third parties (TABLE):
Notes payable Related parties and a Third parties (TABLE)	Notes payable – related parties and a third parties consist of the following:
		March 31,		June 30,
		2015		2014
	Note payable – former Managing Member	$	27,750	$	27,750
	Note payable – related corporation		4,300		4,300
	Notes payable – stockholders		13,000		13,000
	Convertible notes payable		977,241		729,120
	Total		1,022,291		774,170
	Convertible notes payable, discount		-178,460		-126,722
	Total, net of discount		868,831		647,448
	Less current portion		868,831		647,448
	Long-term debt	$	-	$	-

NONCONVERTABLE_DEBT_TABLES

NON-CONVERTABLE DEBT (TABLES)	9 Months Ended
	Mar. 31, 2015
NON-CONVERTABLE DEBT (TABLES):
NON-CONVERTABLE DEBT (TABLES)	Ten separate notes form an investor were received in 2013 as follows:
	Date Issued	Maturity Date		Interest rate	Amount
	23-Feb-13	30-Jun-14		10%	$	100,000
	February 27,2013	30-Jun-14		8%	$	1,500
	14-Mar-13	30-Jun-14		8%	$	6,500
	April 23,2013	30-Jun-14		8%	$	5,000
	9-May-13	30-Jun-14		8%	$	10,000
	30-Jun-13	30-Jun-14		8%	$	7,500
	11-Jul-13	30-Jun-14		8%	$	10,000
	29-Jul-13	30-Jun-14		8%	$	10,000
	23-Aug-13	June 30,2014		8%	$	13,000
	29-Aug-13	30-Jun-14		10%	$	9,000
	Various*	On demand		-0-%		12,184
	Total for 2013				$	184,684
SCHEDULE OF NON CONVERTIABLE DEBT SUMMARY (TABLES)	Non-Convertible Debt Summary
	2011 notes	$	217,000
	2012 notes		80,000
	2013 notes		184,684
	Total Non-Convertible Debt	$	481,684

Recovered_Sheet1

Options, Warrants And Stockbased Compensation (TABLE)	9 Months Ended
	Mar. 31, 2015
OPTIONS, WARRANTS AND STOCK-BASED COMPENSATION(TABLE):
Schedule of Weighted Average Number of Shares	The following weighted average assumptions were used to estimate the fair value of stock options using the Black-Scholes option pricing model:
			Three Months Ended		Three Months Ended
			31-Mar-15		31-Mar-14
	Risk-free interest rate		0.62% - 0.72%		0.90% - 0.96%
	Expected dividend yield		-		-
	Expected term		3.25 - 5.5 years		5.5 years
	Forfeiture rate		0%		0%
	Expected volatility		244.90% - 262.52%		122.33% - 124.91%
Summary of Option Activity (TABLE)	A summary of option activity as of March 31, 2015 and for the three months then ended is presented below. All information is presented pre-split:
	Options		Shares		Weighted Average Exercise Price		Weighted Average Remaining Contractual Term	Aggregate Intrinsic Value
	Outstanding at June 30, 2012		186,760		$	15	8.84 years	$	-
	Granted		-			-	-		-
	Exercised		-			-	-		-
	Forfeited or expired		-			-	-		-
	Outstanding at June 30, 2013		186,760		$	15	7.84 years	$	-
	Granted		-			-	-		-
	Exercised		-			-	-		-
	Forfeited		-			-	-		-
	Exercisable at June 30, 2014 and March 31, 2015		186,760		$	15	6.84 years	$	-
Summary of Warrants Outstanding (TABLE)	The following table summarizes the warrants outstanding at June 30, 2014 adjusted for the 1:250 stock split which took effect on September 4, 2014:
	Exercise price			Number		Expiration Date
	$	2.5		2,000		2/10/17
	$	2.5		4,000		2/17/17
	$	2.5		1,250		4/18/17
	$	2.5		800		8/15/17
	$	2.5		200		8/20/17
	$	2.5		1,000		9/14/17
	$	2.5		1,000		10/2/17
				10,250

Computation_of_Diluted_EPS_TAB

Computation of Diluted EPS (TABLE)	9 Months Ended
	Mar. 31, 2015
COMPUTATION OF DILUTED EPS (TABLE):
COMPUTATION OF DILUTED EPS (TABLE)	Securities that could potentially dilute basic earnings (loss) per share ("EPS") as of March 31, 2015 and 2014, and that were not included in the computation of diluted EPS because to do so would have been anti-dilutive consist of the following:
		Potentially Outstanding
		Dilutive Common Shares
		For the Interim Period	For the Interim Period
		Ended	Ended
		March 31, 2015	March 31, 2014
	Preferred stock- Series E 5% Convertible; stated value $1,000 per share; -0-  issued and outstanding at March 31 2015 and June 30, 2014, respectively	-	-
		180,000	180,000
	Preferred stock- Series F Convertible; stated value $1,000 per share; 90 shares issued and outstanding at March  31, 2015 and June 30, 2014
		-	-
	Preferred stock- Series G Convertible; stated value $1,000 per share; No shares issued and outstanding at March 31, 2015 and June 30, 2014
		1	1
	Preferred stock- Series H Convertible; stated value $1,000 per share; 51 shares issued and outstanding at March 31, 2015 and June 30, 2014
		-	1,194,412
	Preferred stock- Series I Convertible; stated value $1,000 per share; -0- and 3,500 shares issued and outstanding at March 31, 2015 and June 30, 2014, respectively. Par value $.001, 3,500 shares authorized
		68,501,938	-
	Preferred stock- Series J 10% Convertible; stated value $1,000 per share; 1,525 and -0- shares issued and outstanding at March 31, 2015 and June 30, 2014, respectively. Par value $.001, 3,500 shares authorized. Liquidation preference of $1,525,000 at March 31, 2015
		68,501,938	-
	Preferred stock- Series K 10% Convertible; stated value $1,000 per share; 750 and -0- issued and outstanding at March 31, 2015 and June 30, 2014, respectively. Par value $.001, 3,500 shares authorized. Liquidation preference of $750,000 at March 31, 2015
		342,646,780	1,985,099
	Convertible Notes Payable*
	Stock options	186,760	186,760
	Restricted stock award	10,000	10,000
	Warrants	10,250	10,250
		480,037,667	3,566,522

OPERATING_SEGMENTS_TABLES

OPERATING SEGMENTS (TABLES)	9 Months Ended
	Mar. 31, 2015
OPERATING SEGMENTS (TABLES):
DATA FOR THE THREE MONTHS ENDED March 31,2015
			Three Months Ended March 31, 2015
			Medical Diagnostics		Beverages		Unallocated		Total
	Revenues	$	-	$	-	$	-	$	-
	Cost of Goods Sold		-		-		-		-
	Total Operating Expenses		4,780		150,271		112,203		267,254
	Operating Income (Loss)		-4,780		-150,271		-112,203		-155,052
	Other Income (Expense)		-		-10,853		-442,032		-452,885
	Net Income		-4,780		-161,125		-554,235		-607,937
	Total Assets	$	45,258	$	290,001	$	4,332,600	$	4,667,859
DATA FOR THE THREE MONTHS ENDED MARCH 31, 2014			Three Months Ended March 31, 2014
			Medical Diagnostics		Beverages		Unallocated		Total
	Revenues	$	54,000	$	-	$	-	$	54,000
	Cost of Goods Sold		-		-		-		-
	Total Operating Expenses		66,360		-		-221,858		-155,498
	Operating Income (Loss)		-12,360		-		221,858		209,498
	Other Income (Expense)		-3,024		-		-131,133		-134,157
	Net Income		-15,384		-		90,726		75,341
	Total Assets	$	64,378	$	-	$	1,039,074	$	1,103,452
DATA FOR THE NINE MONTHS ENDED MARCH 31,2015			Nine Months Ended March 31, 2015
			Medical Diagnostics		Beverages		Unallocated		Total
	Revenues	$	54,000	$	4,581	$	-	$	58,581
	Cost of Goods Sold		-		5,779		-		5,779
	Total Operating Expenses		68,633		252,379		389,604		710,617
	Operating Income (Loss)		-14,633		-253,578		-389,604		-657,815
	Other Income (Expense)		-		-10,853		-1,192,321		-1,203,174
	Net Income		-14,633		-264,431		-1,581,926		-1,860,990
	Total Assets	$	45,258	$	290,001	$	4,332,600	$	4,667,859
DATA FOR THE NINE MONTHS ENDED MARCH 31,2014			Nine Months Ended March 31, 2014
			Medical Diagnostics		Beverages		Unallocated		Total
	Revenues	$	162,000	$	-	$	-	$	162,000
	Cost of Goods Sold		-		-		-		-
	Total Operating Expenses		150,277		-		406,748		557,025
	Operating Income (Loss)		11,723		-		-406,748		-395,025
	Other Income (Expense)		3,024		-		-609,448		-606,424
	Net Income		14,747		-		-1,016,196		-1,001,449
	Total Assets	$	64,378	$	-	$	1,039,074	$	1,103,452

Nature_of_Operations_And_Basis

Nature of Operations And Basis Of Presentation (Details) (USD $)	Feb. 05, 2015	Oct. 16, 2014
Basis Of Presentation
Percentage of holding of common stock and all the Series A Preferred Stock of Village Tea		70.00%
Accelpath issued shares of a newly designated series of convertible preferred stock to the Sellers, Series J.		1,525
The Series J Preferred Stock has a stated value per share equal to		$1,000
The Series J Preferred Stock shall pay an annual dividend in cash or common stock, and shall be convertible at the holder's option		10.00%
Accelpath at a conversion price equal to eighty percent		80.00%
Accelpath agreed to assume worth of the debt obligations of Village Tea in connection with the Agreement.		$538,500
Under the terms of the Agreement, the Sellers will sell 52.78 membership interests in STI, representing outstanding membership units of STI	52.00%
Company shall issue shares of a newly created Series K preferred stock with a stated value of	750,000
Restricted common stock of the Company with state value	55,000
The company will assume STI worth debt	485,516.53
Sellers shall be entitled to additional shares of Preferred Stock with a stated value	$2,250,000

Going_Concern_Uncertainity_and

Going Concern Uncertainity and management's Plan (DETAILS) (USD $)	9 Months Ended	12 Months Ended
	Mar. 31, 2015	Jun. 30, 2014
GOING CONCERN UNCERTAINTY AND MANAGEMENT'S PLAN TEXT
Net Loss Applicable to Common Shareholders.	$1,836,828	$2,510,089

Company_Deficit_Details

Company Deficit (Details) (USD $)	Mar. 31, 2015
Working Capital and Deficit Details
Company had a working capital deficit of	$5,673,925
A stockholders' deficit of	$1,308,175

Liabilities_purchase_agreement

Liabilities purchase agreement (Details) (USD $)	19-May-15	Mar. 31, 2015	Oct. 07, 2013
Liabilities purchase agreement
Settlement of certain liabilities owed by the Company in the aggregate amount			$1,537,455
Promissory note in the principal amountmaturing six months from the date of issuance, as a fee to ASC issued			75,000
ASC had purchased the liabilities from the Company's creditors (both affiliated and non-affiliated) with a face amount			1,537,455
The total amount of liabilities, as reported by the Company in its Form 10-Q		3,961,093
Claim Amount and the Fee Note represented in total liabilities		1,612,455
The fair market value of such Settlement Shares and all other amounts to be received by ASC would equal approximately to an amount		2,145,000
The number of shares beneficially owned by ASC shall not exceed		9.99%
Worth of liabilities through the issuance of common stock	2,145,000
Worth of liabilities through the issuance of common stock per share	$0.00
Company would issue an aggregate number of shares		2,145,000,000
Company has issued Settlement Shares to ASC		59,697,000
Value of the shares upon issuance is recorded as an Other current asset		$34,352

Notes_payable_related_parties_

Notes payable - related parties and a third parties consist of the following (Details) (USD $)	Mar. 31, 2015	Jun. 30, 2014
Notes payable - related parties and a third parties consist of
Note payable - former Managing Member	$27,750
Note payable - related corporation	4,300	4,300
Notes payable - stockholders	13,000	13,000
Convertible notes payable,	977,241
Total convertible notes payable.	1,022,291	774,170
Convertible notes payable, discount	-178,460	-126,722
Total, net of discount	868,331	647,448
Less current portion	868,831	647,448
Long-term debt.	$0	$0

Notes_payables_for_consulting_

Notes payables for consulting services (Details) (USD $)	9 Months Ended
	Mar. 31, 2015
Notes payables for consulting services
Company has issued notes for consulting purposes	$270,000
Company has issued notes for cash	172,500
Consulting notes are comprised of nine notes	$30,000
The third party has the option to convert all or a portion of the note plus accrued interest into common stock at a conversion price equal to % of the lowest closing bid price for the ten days prior to the conversion	50.00%
Notes for cash are comprised of nine notes which convert into common stock discount to the prevailing market price minimum	42.00%
Notes for cash are comprised of Nine notes which convert into common stock discount to the prevailing market price maximum	50.00%

Interest_Expense_Details

Interest Expense (Details) (USD $)	3 Months Ended		9 Months Ended
	Mar. 31, 2015	Mar. 31, 2014	Mar. 31, 2015	Mar. 31, 2014
Interest Expense Details
Interest expense on notes payable, including amortization of the discount on the convertible notes and the accrual of the Original Issue Discount	$152,473	$137,181	$444,937	$305,113

NONCONVERTIBLE_DEBT_Details

NON-CONVERTIBLE DEBT (Details) (USD $)	Interest Rate	Amount
Opening balance at Jun. 30, 2014	$0	$0
(Note) Date Issued February 23, 2013 and Maturity date June 30, 2014	0.1	100,000
(Note)Date Issued February 27, 2013 and Maturity date June 30, 2014	0.08	1,500
(Note)Date Issued Marh 14, 2013 and Maturity date June 30, 2014	0.08	6,500
(Note)Date Issued April 23, 2013 and Maturity date June 30, 2014	0.08	5,000
(Note)Date Issued May 9, 2013 and Maturity date June 30, 2014	0.08	10,000
(Note)Date Issued June 30, 2013 and Maturity date June 30, 2014	0.08	7,500
(Note)Date Issued July 11, 2013 and Maturity date June 30, 2014	0.08	10,000
(Note)Date Issued July 29, 2013 and Maturity date June 30, 2014	0.08	10,000
(Note)Date Issued August 23, 2013 and Maturity date June 30, 2014	0.08	13,000
(Note)Date Issued August 29, 2013 and Maturity date June 30, 2014	0.1	9,000
Various on demand	0	12,184
Total for 2013	0	184,684
Closing balance at Mar. 31, 2015	0	0
Opening balance at Mar. 31, 2015	$0	$0

Non_convertible_debtexpenses_D

Non convertible debt-expenses (Details) (USD $)	Mar. 15, 2011
non convertible debt-expenses Details
An investor lent the Company for operating expenses	$80,000
Beverley Reif lent the Company , note bore interest rate 5%	100,000
If the note were not paid by maturity, the interest rate would increase to	18.00%
Dana Pope lent the Company ,The note bore an interest rate of 5%	57,000
Dana pope note were not paid by maturity, the interest rate would increase to	18.00%
An investor lent the Company for operating expenses throughout the year	$60,000

Summary_of_NonConvertible_Debt

Summary of Non-Convertible Debt (Details) (USD $)	Mar. 31, 2015
Summary of Non-Convertible Debt
Non-Convertible Debt 2011 notes	$217,000
Non-Convertible Debt 2012 notes	80,000
Non-Convertible Debt 2013 notes	184,684
Total Non-Convertible Debt notes	$481,684

Preferred_Stock_issuance_Detai

Preferred Stock issuance (Details) (USD $)	3 Months Ended
	Mar. 31, 2015	Mar. 31, 2014
Series E Preferred stock shares
Company had Series E 5% Convertible Preferred Stock outstanding shares	0
Company exchanged its remaining 100 shares of Series E Preferred Stock		$14,282
Company had accrued dividends into a secured note		114,282
The Company accrued cash dividends payable	$0	$1,139

Series_F_Preferred_Stock_share

Series F Preferred Stock share (Details) (USD $)	Sep. 10, 2012	Sep. 07, 2012
Series F Preferred Stock shareDetails
Company authorized 100 shares of Series F Convertible Preferred Stock, with a stated value		$1,000
Conversion Price per share(F SERIES)		$0.02
Series F Preferred are currently convertible into shares of common stock		180,000
Shares of common stock using a Conversion Price per share		$5
Company issued 90 shares of its Series F Preferred Stock for the purchase price of	$90,000
The 90 shares of Series F Preferred are currently convertible into shares of common stock	180,000
Beneficial conversion feature for the issuance of the 90 shares of Series F Preferred Stock	360,000

Series_G_Preferred_Stock_share

Series G Preferred Stock share (Details) (USD $)	Sep. 18, 2012
Series G Preferred Stock share Details
Company authorized 1,250 shares of Series G Convertible Preferred Stock, with a stated value	$1,000
Conversion price per share (G) series	$0.02
Series G Preferred are convertible into shares of common stock	62,500,000

Series_H_Preferred_Stock_share

Series H Preferred Stock share (Details) (USD $)	Apr. 02, 2013
Series H Preferred Stock share
One share of Series H Preferred has voting rights equal	$0.02
Series H Stockholder holds the total voting power of all issued and outstanding voting capital of the Company	51.00%

Series_I_Preferred_Stock_share

Series I Preferred Stock share (Details) (USD $)	Oct. 24, 2013
Series I Preferred Stock share Details
Common stock its holds in EIP and the return and surrender by EIP of shares of Series I Preferred Stock	$3,500

Series_J_Preferred_Stock_share

Series J Preferred Stock share (Details) (USD $)	Oct. 16, 2014
Series J Preferred Stock share Details
Percentage of holding of common stock and all the Series A Preferred Stock of Village Tea	70.00%
Accelbrands issued shares of a newly designated series of convertible preferred stock to the Sellers	1,525
The Series J Preferred Stock has a stated value per share equal to the amount	$1,000
The Series J Preferred Stock shall pay an annual dividend	10.00%
Accelpath at a conversion price equal to the lowest closing bid price for the Common Stock	80.00%

Series_K_Preferred_Stock_share

Series K Preferred Stock share (Details) (USD $)	Feb. 05, 2015
Series J Preferred Stock share Details
Under the terms of the Agreement, the Sellers will sell 52.78 membership interests in STI	52.00%
Company shall issue shares of a newly created Series K preferred stock SHARES with stated value	$750,000
Series K stated value of restricted comon stock	55,000
STI debt amounted	485,516.53
Sellers shall be entitled to additional shares of Preferred Stock with a stated value of Series K	$2,250,000

Common_Stock_Details

Common Stock (Details) (USD $)	9 Months Ended
	Mar. 31, 2015
Common Stock Details
Number of shares require for 1 share under reverse split	$250
Company issued shares pursuant to the conversion of debt	608,833,551
Shares pursuant to the 3a10 program	59,697,000
Fractional shares associated with the reverse split	3,763

Equity_Purchase_Agreement_Deta

Equity Purchase Agreement (Details) (USD $)	Jul. 19, 2012	Mar. 07, 2011
Equity Purchase Agreement Details
A third party committed to purchase up to shares of common stock		5,000,000
Equity Purchase Agreement will be the average of the lowest three closing bid prices,		95.00%
Company received proceeds for the sale of 2,807 common stock shares	$6,000

2011_Equity_Incentive_Plan_Det

2011 Equity Incentive Plan (Details)	Jan. 01, 2013	Mar. 04, 2011
2011 Equity Incentive Plan Details
Board of Directors adopted the 2011 Equity Incentive Plan and reserved shares of common stock for issuance to Employees		50,000,000
Total number of shares outstanding on December 31st of the preceding year		5.00%
Shares outstanding on December 31st of the preceding year		3,000,000
The number of shares reserved under the plan automatically increased to	56,000,000

Weighted_average_assumptions_w

Weighted average assumptions were used to estimate the fair value of stock options using the Black-Scholes option pricing model: (Details)	3 Months Ended
	Mar. 31, 2015	Mar. 31, 2014
Weighted average assumptions were used to estimate the fair value of stock options using the Black-Scholes option pricing model:
Risk-free interest rate Minimum	0.62%	0.90%
Risk-free interest rate Maximum	0.72%	0.96%
Expected dividend yield	0	0
Expected term minimum in years	3.25	5.5
Expected term maximum in years	5.5	0
Forfeiture rate	0.00%	0.00%
Expected volatility Minimum	244.90%	122.33%
Expected volatility maximum	262.52%	124.91%

A_summary_of_option_activity_D

A summary of option activity (Details) (USD $)	Shares	Weighted Average Exercise price	Weighted Average Remaining Contractual Term	Aggregate Intrinsic value
Outstanding option at Jun. 30, 2012	$186,760	$15	$8.84	$0
Granted	0			0
Exercised		0		0
Forfeited or expired				0
Outstanding option , at Jun. 30, 2013	186,760	15	7.84	0
Granted;				0
Exercised;				0
Forfeited;	0			0
Exercisable at June 30, 2014 and March 31, 2015	186,760	15	6.84	0
Outstanding option . at Mar. 31, 2015	0	0	0	0

Board_of_Directors_granted_sto

Board of Directors granted stock options (Details) (USD $)	Jun. 03, 2012	Jan. 12, 2012	Dec. 14, 2011	Aug. 12, 2011	13-May-11	Apr. 06, 2011
Granted Stock option details
Board of Directors granted stock options to purchase shares of common stock	3,400	480	10,000	480	3,000	169,450
Granted Stock option exercise price per share	$13.60	$1.25	$3.75	$12.50	$15	$16.25
The weighted average fair value of the options granted was estimated per share	$3.88	$1	$2	$10.75	$0	$14.60
These options vest over three years and have a term of	10	10	10	10	0	10

Restricted_Stock_Details

Restricted Stock (Details) (USD $)	Mar. 31, 2015	Sep. 15, 2012	Jun. 15, 2012	Mar. 15, 2012
Restricted Stock Details
Company agreed to issue a restricted stock award of shares				10,000
shares of common stock to a consultant for services to be rendered with shares vesting		5,000	5,000
Consulting expense recorded for the restricted stock award	$29,167

Warrants_Details

Warrants (Details) (USD $)	9 Months Ended
	Mar. 31, 2015
Warrants outstanding
Warrants to purchase shares	200,000
Warrants exercise price	$1.89
Company issued warrants in connection with convertible notes payable	2,000,000
Company issued warrants in connection with convertible notes payable excerise price	$2.50
Company has reserved shares of common stock for the exercise of outstanding warrants	2,075,000

Summary_of_Warrants_outstandin

Summary of Warrants outstanding (Details) (USD $)	Warrant Exercise price	Warrant Number
Expiration date 02/10/2017 at Jun. 30, 2014	2.5	2,000
Expiration date 02/17/2017	2.5	4,000
Expiration date 04/18/2017	2.5	1,250
Expiration date 08/15/2017	2.5	800
Expiration date 08/20/2017	2.5	200
Expiration date 09/14/2017	2.5	1,000
Expiration date 10/02/2017	2.5	1,000
Total Number of warrants outstanding at Mar. 31, 2015	0	10,250

Fair_value_of_Warrants_granted

Fair value of Warrants granted (Details)	3 Months Ended
	Mar. 31, 2014
Warrants issued Details
Fair value of the warrants granted per share	0.0095
Risk free Interest rate minimum	0.60%
Risk free Interest rate maximum	0.72%
Expected Dividend yeield	0.00%
Expected Term in years	5
Expected Volatility minimum.	244.07%
Expected Volatility maximum.	248.52%
Weighted average remaining life of the warrants in years	3.86

Stock_Award_Plan_Details

Stock Award Plan (Details) (USD $)	Mar. 31, 2014
Stock Award Plan Details
Company has shares available for future grant under the Plan.	$111,845

Net_loss_per_share_Details

Net loss per share (Details) (USD $)	Mar. 31, 2015	Mar. 31, 2014
Shares Potentially Issuable
Series E Convertible Preferred Stock	0	0
Series F Convertible Preferred Stock	180,000	180,000
Series G Convertible Preferred Stock	0	0
Series H Convertible Preferred Stock	1	1
Series I Convertible Preferred Stock	0	1,194,412
Series J Convertible Preferred Stock	$68,501,938	$0
Series K Convertible Preferred Stock	68,501,938	0
Convertible notes payable:	342,646,780	1,985,099
Stock options	186,760	186,760
Restricted stock award	10,000	10,000
Warrants	10,250	10,250
Total NET	$480,037,667	$3,566,522

Consulting_Agreements_Details

Consulting Agreements (Details) (USD $)	9 Months Ended
	Mar. 31, 2015
Consulting Agreements Details
The Company signed a consulting agreement which calls for monthly payment	$30,000
Company has incurred convertible note1	90,000
Company has incurred convertible note2	$270,000

OPERATING_SEGMENTSDetails

OPERATING SEGMENTS(Details) (USD $)	Medical Diagnostics	Beverages	Unallocated	Total
Opening balance at Jun. 30, 2014	$0	$0	$0	$0
Revenues.	0	0	0	0
Cost of Goods Sold.	0			0
Total Operating Expenses.	4,780	150,271	112,203	267,254
Operating Income (Loss).	-4,780	-150,271	-112,203	-155,052
Other Income (Expense).	0	-10,853	-442,032	-452,885
Net Income.	-4,780	-161,125	-554,235	-607,937
Total Assets.	45,258	290,001	4,332,600	4,667,859
Revenues;.	54,000	0	0	54,000
Cost of Goods Sold;.	0	0	0	0
Total Operating Expenses;.	66,360	0	-221,858	-155,498
Operating Income (Loss);.	-12,360	0	221,858	209,498
Other Income (Expense);.	-3,024	0	-131,133	-134,157
Net Income;.	-15,384	0	90,726	75,341
Total Assets;.	64,378	0	1,039,074	1,103,452
Revenues:	54,000	4,581	0	58,581
Cost of Goods Sold:	0	5,779	0	5,779
Total Operating Expenses:	68,633	252,379	389,604	710,617
Operating Income (Loss):	-14,633	-253,578	-389,604	-657,815
Other Income (Expense):	0	-10,853	-1,192,321	-1,203,174
Net Income:	-14,633	-264,431	-1,581,926	-1,860,990
Total Assets:	45,258	290,001	4,332,600	4,667,859
Revenues:-	162,000	0	0	162,000
Cost of Goods Sold:-	0	0	0	0
Total Operating Expenses:-	150,277	0	406,748	557,025
Operating Income (Loss):-	11,723	0	-406,748	-395,025
Other Income (Expense):-	3,024	0	-609,448	-606,424
Net Income:-	14,747	0	-1,016,196	-1,001,449
Total Assets:-	64,378	0	1,039,074	1,103,452
Closing balance at Mar. 31, 2015	$0	$0	$0	$0